Bicycle Therapeutics (BCYC) grants COO 60,000 employee stock options
Rhea-AI Filing Summary
Bicycle Therapeutics plc reported that Chief Operating Officer Jennifer Scott Perry received an employee stock option grant covering 60,000 Ordinary Shares on July 15, 2026. The option has a $4.21 exercise price, expires July 15, 2036, and vests 25% on July 15, 2027, with the remainder vesting in 36 equal monthly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Perry Jennifer Scott
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 60,000 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 60,000 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 60,000 shares
Exercise price: $4.21 per share
Option expiration: July 15, 2036
+2 more
5 metrics
Option grant size
60,000 shares
Employee stock option granted to the COO on July 15, 2026
Exercise price
$4.21 per share
Exercise price of the employee stock option
Option expiration
July 15, 2036
Expiration date of the granted option
Underlying shares
60,000 Ordinary Shares
Shares underlying the employee stock option grant
Post-grant option holdings
60,000 options
Total derivative securities held after the reported acquisition
Key Terms
Employee Stock Option, Ordinary Shares, vesting
3 terms
Employee Stock Option financial
"Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
vesting financial
"This option shall vest with respect to one-fourth of the shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did BCYC report for Jennifer Scott Perry?
Bicycle Therapeutics reported that COO Jennifer Scott Perry received an employee stock option grant for 60,000 Ordinary Shares. The award was granted on July 15, 2026 as equity compensation and represents a new derivative position rather than a market purchase or sale of existing shares.
What is the exercise price and expiration of the BCYC option grant?
The employee stock option has an exercise price of $4.21 per share and expires on July 15, 2036. These terms define the price Perry must pay to buy shares and the last date she can exercise the option.
How does the Bicycle Therapeutics (BCYC) option grant vest?
The option will vest 25% of the underlying shares on July 15, 2027. The remaining shares vest in 36 equal monthly installments thereafter, creating a four-year vesting schedule tied to continued service.
Was the BCYC Form 4 transaction for Jennifer Scott Perry under a Rule 10b5-1 plan?
The reported data indicate that the Rule 10b5-1 checkbox is not selected for this transaction. This suggests the option grant was not reported as occurring under a pre-arranged Rule 10b5-1 trading plan.
What are Jennifer Scott Perry's BCYC option holdings after this grant?
After this transaction, Jennifer Scott Perry is reported as holding 60,000 employee stock options linked to Bicycle Therapeutics Ordinary Shares. These options reflect her total derivative holdings following the grant, subject to the stated vesting schedule and expiration date.